Intranasal Semax Attenuates Behavioral and Cognitive Deficits in a Rat Model of LPS-induced Neuroinflammation — preprint
Vladimir Belyakov, Aisance Tchang · 2026 · SSRN; posted 20 February 2026
Study findings
The preprint reports improvement in behavioral and cognitive measures following intranasal Semax in an LPS-induced inflammation model.
- Population and setting
- 27 male Wistar rats; three groups of nine
- Evidence type
- Animal / experimental
- Source language
- English
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- SSRN lists this as under review; it is not treated as a peer-reviewed publication.
- Small animal experiment. Numerical effect estimates and the full protocol were not independently appraised.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: SSRN preprint
Source access and review scope
SSRN indexed abstract and publication-status field checked; full manuscript not appraised.
Recorded source-check date: 2026-10-11. This date does not imply a completed systematic review.
Source type: Preprint; under review
Open original source or index record ↗
DOI: 10.2139/ssrn.6192725
Citation and original source
Original source: Vladimir Belyakov, Aisance Tchang. Intranasal Semax Attenuates Behavioral and Cognitive Deficits in a Rat Model of LPS-induced Neuroinflammation — preprint SSRN; posted 20 February 2026 2026.
Molekul research summary: https://molekul.io/research/semax-lps-preprint-2026. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry